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Abstract 
Melanin-concentrating hormone (MCH) is a neuropeptide that acts centrally as an 
anabolic signal, while also mediating behaviours such as reward, activity level, and 
anxiety. MCH expressing neurons are limited in their expression being isolated to the 
lateral hypothalamus (LH) and nearby zona incerta (ZI). Despite this limited area of 
expression the neurons project widely throughout the brain. The 
neurotransmitter/neuromodulator dopamine (DA), which is best known for its role in 
reward and locomotion, is released within the LH area. DA action within the LH area is 
known to influence MCH related behaviours: for example, an injection ofDA into the 
LH will decrease food intake. Since MCH promotes food intake and DA has anorexic 
properties in the LH it is hypothesized that DA inhibits the activity of the MCH 
expressing neurons. However, DA's mechanism of action on MCH neurons is not 
known. This study was carried out to determine the cellular mechanisms by which DA 
influences MCH expressing neurons. To determine this MCH neuronal activity was 
monitored using whole cell patch-clamp recordings from LH/ZI containing rat brain 
slices. MCH neurons were identified and distinguished from nearby orexin neurons by 
their electrophysiological characteristics and post-hoc immunohistochemistry. All drugs 
were bath applied. In order to monitor DA' s presynaptic influence y-aminobutyric acid 
(GABA) release was recorded through pharmacologically isolated miniature inhibitory 
postsynaptic currents (rniPSCs). Results showed that DA inhibits the activity of MCH 
expressing neurons through hyperpolarization and a reduction in action potential firing. 
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Furthermore, DA induced a dose dependent outward current. This current was the result 
of G protein-activated inwardly rectifying K+ (GIRK) channel activation. Surprisingly, 
initiation of the GIRK current was not dependent on DA receptor activation but rather on 
the highly expressed adrenergic a 2A receptor. Norepinephrine (NE) also produced a 
reversible, dose dependent outward current in MCH neurons when acting on the 
adrenergic receptors. The DA and NE induced outward currents were of similar 
magnitudes, indicating both have similar efficacies when acting on MCH neurons. 
Monitoring miPSCs revealed that DA had no consistent effect on their frequency or 
amplitude, indicating that DA does not influence synaptic GABA transmission. Overall 
this study demonstrates that DA has a direct postsynaptic inhibitory influence on MCH 
neurons. This inhibition is accomplished though activation of adrenergic receptors and 
the initiation of a GIRK current. Furthermore, this study reveals a cross talk between 
dopaminergic and adrenergic signalling at the cellular level within the LH area. 
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CHAPTER! 
Introduction 
1.1 Overview 
Melanin-concentrating hormone (MCH) is a cyclic neuropeptide that centrally 
participates in the regulation of numerous behaviours including feeding, reward, stress 
and locomotor activity. Through animal studies MCH has been shown to function as an 
anabolic signal in energy homeostasis. It communicates hedonic aspects of feeding, 
activates the stress axis, and decreases an animal ' s activity level. Due to these functions 
an unbalanced regulation of the MCH system may be associated with the development 
and maintenance of obesity. In order to fully understand the MCH system and to develop 
pharmaceutical therapies for diseases like obesity, it is crucial that the cellular 
mechanisms regulating MCH neuronal activity are described. 
The neurotransmitter/neuromodulator dopan1ine (DA) may be one of the critical 
regulators of the MCH system. This is because similar to MCH, DA influences 
behaviours such as feeding, response to reward, and locomotion. Also, DA projections 
are known to intersect MCH's neuronal origins and terminal fields. Thus, some of the 
physiological functions ofDA may be mediated by MCH. However, despite the 
possibility that DA directly influences MCH neuronal activity, its mechanism of action is 
not known. My goal is to determine DA' s effect on MCH neuronal activity and the 
mechanisms regulating it. 
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1.2 History and structure 
The MCH neuropeptide was first identified due to its skin lightening role in 
Teleosts (Baker & Ball, 1975;Westerfield et al. , 1980). The primary sequence was first 
identified in 1983 from isolated chum salmon pituitaries as a 17-amino-acid peptide 
(Kawauchi et al., 1983), with a dicysteine bridge at positions 5 and 14 fom1ing a ring 
structure. Subsequent to its discovery in fish, MCH was identified it the mammalian 
hypothalamus (Vaughan et al., 1989). The mammalian form of MCH is a cyclic 19-
amino-acid peptide that is highly homologous to the chum salmon MCH. Identification of 
the MCH receptor was made collectively (Bachner et al. , 1999;Chambers et al., 
1999;Lembo et al. , 1999;Saito et al. , 1999;Shimomura et al. , 1999) and denoted 
MCHR1. MCH binds to MCHR1 with nanomolar affinity and the receptor can couple to 
Gi, G0 , or Gq proteins to activate multiple intracellular signaling pathways (Hawes et al., 
2000). Subsequent to the identification of MCHR1, a second MCH receptor has been 
identified in humans (An et al., 2001 ;Hawes et al., 2000;Rodriguez et al., 2001) and 
denoted MCHR2. MCH2R was found to be a pseudogene in rodent species, but is 
functional in dogs, ferrets, rhesus monkeys, and humans (Tan et al. , 2002). However, due 
to the lack of available animal models the functional importance of MCHR2 remains 
largely unknown. The overall homology of MCHR2 to MCHR1 is relatively low for a 
family of receptors that bind to the same ligand with about a 38% amino-acid similarity 
(Sailer et al., 2001 ). This indicates that the two receptors are more divergent in evolution 
than other GPCR families. 
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1.3 Expression in the CNS 
Central nervous system (CNS) expression of the MCH neuropeptide is limited to 
the lateral hypothalamus (LH) and the zona incerta (ZI). These neurons project widely 
throughout the brain and are distributed throughout the CNS in patterns that generally 
conform to known projection fields of the LH and ZI (Bittencourt et al., 1992). These 
include the prefrontal cortex, dorsal and ventral striatum, piriform cortex, olfactory 
tubercle, hippocampal formation, nucleus accumbens (NAc ), amygdala, and various 
nuclei in the hindbrain, such as the nucleus tractus solitarius and the parabrachial nucleus. 
MCHRl and MCHR2 expression coincides with MCH neuronal projection fields (An et 
al. , 2001 ;Hervieu et al. , 2000;Hill et al. , 2001;Saito et al. , 2000). 
1.4 Neurochemical properties 
Through quantitative immunocytochemical identification and analysis with laser 
microdissection and semi-quantitative reverse transcriptase polymerase chain reaction 
(RT-PCR) a multi-transcriptional profiling of the intrinsic characteristics of MCH 
neurons in the rat LH was established (Harthoorn et al., 2005). MCH neurons were 
shown to express the neuropeptides MCH, cocaine-and amphetamine regulated transcript 
(CART), and dynorphin. Furthermore, MCH neurons expressed the glutan1ate marker 
vesicular glutamate transporter (VGLUT)-1 and the y-aminobutyric acid (GABA) 
markers glutamic acid decarboxylase (GAD)-65 and GAD-67, thus indicating the 
presence and possible dispersal of both excitatory and inhibitory transmitters. 
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1.5 Physiological Roles of MCH 
1.5.1 Food intake 
MCH was first thought to be involved in food intake because it was expressed 
within the LH. The LH has long been thought of as the "hunger center" of the brain due 
to classic lesion/stimulation studies (for review see Schwartz et al. , 2000). This notion 
was supported when it was observed that MCH rnRNA was increased in leptin deficient, 
obese, ob/ob mice (Zhang et al. , 1994). An increase in MCH RNA was also observed 
after fasting in both lean and ob/ob mice (Qu et al., 1996). Furthermore, 
intracerebroventricular (ICV) injection of MCH tripled food intake in rodents, an effect 
that lasted for up to six hours (Qu et al. , 1996;Rossi et al., 1997). MCH' s role as an 
orexigenic neuropeptide was confirmed through gene knockout and over expression 
studies. It was discovered that when the MCH gene was knocked out (MCH-/-) mice 
were hypophagic and lean compared to their wild type littermates (Shimada et al. , 1998). 
Also, their resting energy expenditure was elevated, which accounted in part for their 
leanness. Furthermore, when the MCH gene was over expressed in mice fed a high fat 
diet they where 12.6% heaver then the wild-type controls fed the same diet. Also the 
obese mice were found to be hyperphagic (Ludwig et al. , 2001). During in-vitro brain 
slice experiments the MCH neuropeptide was shown to stimulate orexigenic neurons of 
the arcuate nucleus, while inhibiting anorexigenic neurons of the ventromedial 
hypothalamus (Davidowa et al. , 2002), thus providing cellular correlates of its role as an 
orexigenic neuropeptide. 
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1.5.2 Reward 
It has been suggested that signaling between the LH and NAc plays an important 
role in communicating the hedonic, or rewarding, aspects of feeding (Saper et al. , 2002). 
Evidence for this view include the fact that the MCHRl is robustly expressed in the 
ventral and dorsal striatum, the terminal fields of midbrain dopaminergic neurons which 
are involved in mediating reward (Saito et al. , 2001). Furthermore, injection ofMCH 
directly into the medial NAc shell increases food intake (Georgescu et al. , 2005). 
Research to date suggests that MCH signaling in the NAc is a starvation induced signal 
that influences the reward pathway to increase the drive to feed (Georgescu eta/., 
2005;Kelley & Berridge, 2002;Saper eta/., 2002). 
1.5.3 Other Behaviours 
MCH is believed to play a physiological role to suppress excessive activity. In 
support of this, MCH injected ICV in rats has been shown to inhibit the increase in 
locomotor activity, grooming, and rearing induced by neuropeptide E-I (peptide produced 
from the same prohormone as MCH) injection (Sanchez et al. , 1997). Also, genetic 
inactivation of MCHRl in mice results in increased spontaneous locomotor activity 
(Marsh et al. , 2002). 
MCH neuronal activation has also been described to promote sleep following 
sustained waking (Modirrousta et al. , 2005). If MCH does in fact decrease activity level 
and promote sleep, then direct inhibition of MCH neurons by arousal systems would be a 
means to prevent the opposing effects of MCH. This is in fact the case with 
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neurotransmitters that can initiate arousal such as norepinephrine (NE), serotonin, 
muscarine, and cholinergic agonists, inhibit the activity ofMCH neurons (van den Pol et 
al. , 2004;Wollmann et al., 2005). 
MCH is also believed to play a role in the physiological regulation of anxiety and 
stress. Several lines of evidence show that MCH activates stress responses and induces 
depressive and anxiety-like behaviours, while the blockade of MCHRl results in 
antidepressant and anxiolytic effects in various rodent models. MCH has been shown to 
activate the hypothalamic-pituitary adrenal (HP A) axis (Kennedy et al. 2003), with ICV 
injection of MCH increasing circulating adrenocorticotropic hormone (ACTH) up to 
10 min post injection. Furthermore, rats given the MCHRl antagonist, SNAP7941 , 
showed a decrease in anxiety and depression during a forced swim test (Borowsky et al., 
2002). Antidepressant effects have also been observed after MCHRl antagonist injection 
into the medial shell of the NAc (Georgescu et al., 2005). This suggests that MCHRl 
may play a substantial role in mediating anxiety and depressive-like behaviours and may 
form the basis for future pharmaceutical approaches to the treatment of these diseases. 
1.6 Electropbysiological properties 
Knowledge of the electrophysiological properties of MCH neurons is crucial for 
the identification of the cells in in-vitro brain slice preparation while also providing a 
foundation for the understanding of all MCH governed behaviours. MCH neurons are 
intermixed with another population of peptidergic neurons, i.e. orexin neurons, which 
have similar morphological characteristics. Because they cannot be distinguished by their 
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appearance with differential interference contrast optics, with which we identify neurons 
suitable for recordings in brain slices, differences in their electrophysiological properties 
are used. Orexin neurons are also known as an important regulator of food intake (for 
review see Sakurai T., 2006) and thus a significant research topic, however, this thesis 
will only focus on MCH neurons. MCH neuronal electrophysiological properties do not 
correspond to the spontaneously active orexin neurons. In a previous study we found in 
in-vitro acute brain slice preparation that MCH neurons were relatively hyperpolarized 
with an average resting membrane potential of -58.8mV, while the orexin neurons were 
comparatively depolarized at an average of -48.6mV (Alberto et al. , 2006). Other 
electrical properties of MCH neurons provide insight into their lack of spontaneous 
activity. They do not have an Ih (sag during a hyperpolarizing current pulse) or rebound 
depolarization (after a hyperpolarizing current pulse) as the orexin neurons do. However, 
they do show strong spike rate adaptation during depolarization current pulses (Alberto et 
al. , 2006;Eggerrnann et al., 2003;Gao et al. , 2003). Overall compared to spontaneously 
active orexin neurons the electrophysiological properties of MCH neurons appear to 
maintain quiescence when synaptic activity is absent. 
1.7 Neurotransmitter interactions 
MCH neurons receive a variety of inputs from different neurotransmitter systems 
that regulate their activity. For example, glutamate, ATP and orexin A and orexin B 
depolarize and increase the activity ofMCH neurons (van den Pol eta!., 2004). However 
neuropeptide Y (NPY), a potent orexigenic hypothalamic neuropeptide, inhibits MCH 
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neurons (van den Pol et al. , 2004). This may be a negative feedback mechanism due to 
the fact that MCH stimulates NPY neurons (Davidowa et al. , 2002). Other 
neurotransmitters, including norepinephrine, serotonin, muscarine or cholinergic 
agonists, inhibit MCH neurons (van den Pol et al. , 2004;Wollmann et al. , 2005). 
Numerous cell surface receptors have been identified on MCH neurons including 
GABA receptors, glutamate receptors, OXRl and OXR2 orexin receptors leptin 
receptors, neuokinin receptors, chemokine receptors, muscarinic receptors, serotoninergic 
receptors, and a2-adrenoceptors (Gao et al. , 2003 ;Griffond et al. , 1997;Guyon et al. , 
2005;Hakansson et al. , 1999;van den Pol et al., 2004). DA receptors have also been 
identified in the LH area (Bubser et al. , 2005;Fetissov et al. , 2002). Overall MCH 
neurons receive numerous excitatory and inhibitory afferents signals that are processed 
by the corresponding cell surface receptor. The cellular mechanisms that are initiated by 
the activated receptors determine the cellular response and consequently the functional 
behaviour. 
1.8 DA expression in CNS and association with MCH neurons 
The neurotransmitter/neuromodulator DA is largely known for its involvement in 
modulating the reward and motor systems. DAis expressed within neurons located in 
several regions of the mammalian CNS including the substantia nigra (SN), ventral 
tegmental area (VT A), and the retrorubal area. Doparninergic neurons are also located in 
the hypothalamus within the arcuate nucleus and Zl. Some of these areas form the origin 
for the three main domaminergic pathways, the nigrostriatal, the mesolimbocortical and 
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the tuberoinfundibular pathway (for review see Bjorklund & Dunnett, 2007). With 
respect to MCH neurons the majority of the DA fibers within the LH area arise from the 
VT A (Leibowitz & Brown, 1980; Yoshida et al., 2006), and, DA has been shown to be 
released within the LH (Fetissov et al. , 2000). Furthermore, DA expressing neurons exist 
within the ZI (Bjorklund et al. , 1975). Therefore, DAis positioned to directly interact 
with MCH neurons and possibly influence their activity. 
DA receptors are expressed widely throughout the brain with high expression 
levels in the striatum, NAc and the prefrontal cortex (Bouthenet et al. , 1991 ;Dearry et al. , 
1990). There are five subtypes ofDA receptors classified into 2 groups based on 
sequence homology. DA receptors 1 and 5 are known as D1-like, while DA receptors 2, 
3, and 4 are the D2-like. All DA receptors are G protein dependent with D1-like coupled 
toGs and activating adenylyl cyclase (AC), while D2-like receptors are coupled mainly 
to Guo and inhibit AC (for review see Missale et al., 1998). Activation of either receptor 
can modulate cellular activity through numerous cellular mechanisms such as the 
modulation of cellular calcium and potassium channels, and the Na+-K+-ATPase pump. 
Also, the D2-like receptors can inhibit the Na+/H+ exchanger and activate arachidonic 
release (for review see Missale et al., 1998). 
1.9 DA influences MCH related behaviours 
DA has largely been described based on its involvement with the reward and 
motor systems, however DA has been shown to modulate MCH related behaviours. For 
example DA has been shown to play an important role in regards to energy homeostasis. 
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Transgenic rodent models with altered DA receptors or reuptake have a strong influence 
on weight gain and food reinforcement. It was shown that when DA transporters are 
eliminated, therefore increasing DA levels in the extracellular space, there is a reduction 
in energy intake (Epstein & Leddy, 2006). Furthermore, DA has been shown to have an 
inhibitory impact on food intake when acting within the LH. DA receptor activation 
inhibits feeding (Sederholm et al ., 2002), while the D2-like receptor antagonist sulpiride 
blocks the anorexic effect of DA in the LH (Parada et al. , 1988). Also, different energy 
states (fasting/obesity) modulate DA receptor expression and DA release within the LH 
(Fetissov et al., 2002). Therefore, DA' s anorexic properties within the LH may be 
mediated at least partially though the modulation of MCH neuronal activity. 
1.10 Summary and Hypothesis 
It is evident that MCH expressing neurons play substantial roles in numerous 
physiological functions including stimulating food intake and maintaining energy 
homeostasis. In contrast, behavioural studies have shown DA to have a negative effect on 
food intake and energy homeostasis when acting within the LH area where MCH neurons 
exist. Therefore, I hypothesized that DA inhibits the activity of MCH neurons. Using the 
in-vitro patch-clamp technique I have examined the effect of DA on the 
electrophysiological activity of MCH neurons and the cellular mechanisms involved. 
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CHAPTER2 
Materials and Methods 
2.1 Animal Model 
Male Sprague Dawley (SD) rats (60-90g) were used in this study and were 
obtained from Memorial University Vivarium (VTlOOO Leica Microsystems). The rats 
were housed with food and water available ad-libitum and with a room temperature of 
21 °C ± 1 °C. Also controlled were light/dark cycle (12/12hrs) humidity, and air 
circulation. All experiments were conducted in accordance with the guidelines set by the 
Canadian Council on Animal Care and were approved by the Memorial University of 
Newfoundland Internal Animal Care Committee. Only the number of animals necessary 
to produce reliable results was used. 
2.2 Slice Preparation 
The rats were deeply anesthetized with halothane and decapitated. The brain was 
removed and with the aid of a vibratome 250f.tm coronal hypothalamic brain slices were 
generated at 0-2°C in buffer solution composed of the following (in mM): 87 NaCl, 2.5 
KCl, 1.25 NaH2P04, 7 MgCb, 0.5 CaCh, 25 NaHC03, 25 glucose, 30 sucrose, 3 pyruvic 
acid, 1 ascorbic acid. Slices were then incubated at 33- 34°C for 30-45 min and then held 
at room temperature in artificial cerebrospinal fluid (ACSF) composed of (in mM) 126 
NaCl, 2.5 KCl, 1.2 NaH2P04, 1.2 MgCh, 2 CaCh, 25 NaHC03, 10 glucose, 1 ascorbic 
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acid. Both solutions were continuously bubbled with a combination of 0 2 (95%) and C02 
(5%). 
2.3 Setup 
A hemisected brain slice was placed in the recording chamber of the microscope 
setup and continuously perfused with 33- 34°C ACSF at 1.5-2.0ml/min. Whole-cell 
patch-clamp recording was performed using a Multiclamp 700B amplifier and pClamp 
9.2 software (Molecular Devices, Sunnyvale, CA). The pipette tip resistance of the 
recording electrode was 3- 7 MQ when filled with the internal solution composed of (in 
mM): 128 K-gluconate, 8 KCl, 2 MgCh, 0.2 EGTA, 10 HEPES, 4 Na2-ATP, 0.3 Na-
GTP, pH 7.3. A high chloride concentration internal solution composed of(in mM): 132 
KCl, 2 MgCh, 0.2 EGTA, 10 HEPES, 4 Na2-ATP, 0.3 Na-GTP, pH 7.3, was used to aid 
in miniature inhibitory postsynaptic current (miPSC) detection. Biocytin (1-1.5 mg/ml) 
was also included in the internal solution to label recorded neurons. 
2.4 Cell Identification 
To aid in the localization of MCH neurons, an infrared differential interference 
contrast microscope (IR-DIC) (DMLFSA; Leica Microsystems) was used for visual 
detection. Neurons adjacently lateral and dorsal to the fornix with a diameter of 1 0-20!J.m 
were selected. Once the cells were patched they were injected with a series of 
hyperpolarizing and depolarizing 300ms step pulses in current clamp mode in order to 
characterize the electrophysiological properties of the cell. 
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2.5 Electrophysiological Recordings 
2.5.1 Current-clamp mode 
Current-clamp mode was used to monitor membrane potential and action potential 
firing. The current was clamped at 0 pA so the cells could remain at rest. Because MCH 
neurons are silent at rest in our preparation, 200 pA depolarization current pulses 
300msec in duration were given every 20-60 sec to monitor action potential firing. 
Membrane currents were filtered at 10kHz, sampled at 5 kHz and stored for off-line 
analysis. 
2.5.2 Voltage-clamp mode 
Voltage-clamp mode was used to monitor the direction of current flow. Cells 
were held at a membrane potential of - 70 m V in the presence of tetrodotoxin (TTX) 
CI!lM) to block Na+-dependent action potentials. During miPSC experiments, DNQX 
(lO!lM) and D-AP5 (lO!lM) were used to block glutamatergic transmission in addition to 
TTX. Membrane currents were filtered at 1 kHz, digitized at 5kHz and stored for off-line 
analysis. A 20 m V hyperpolarizing pulse lasting for 100 ms was applied every 20-60 s 
throughout each experiment, and the steady state current and decay rate of the 
capacitance transient were monitored as measures of input resistance and series/access 
resistance, respectively. Cells that showed significant change in these parameters were 
excluded from additional analysis. 
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2.6 Immunohistochemistry 
After the electrophysiological recordings were completed a representative number 
of cells were saved for immunohistochemical analysis. When the electrophysiological 
recording was completed the brain slice was immediately placed in 4% paraformaldehyde 
in 0.1 M PBS overnight at 4°C, then washed and stored in PBS before the addition of 
primary antibodies. To aid in distinguishing between MCH neurons and the orexin 
neurons that occupy similar areas slices were incubated with anti-orexin A goat 
polyclonal IgG (1 :3000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA) and anti-
MCH rabbit polyclonal IgG (1 :2000 dilution; Phoenix Pharmaceuticals, Belmont CA) 
for 3 days at 4°C. Since all orexin neurons contain both the orexin A and the orexin B 
neuropeptides only anti-orexin A was used. Slices were then washed and treated for 3 h 
with a combination of Cy3-conjugated donkey anti-goat antibody, Cy2-conjugated 
donkey anti-rabbit antibody, and streptavidin-conjugated aminomethylcoumarin acetate 
(AMCA), all at 1:500 dilution at room temperature. Antibodies were diluted with PBS 
with 0.03% Triton X. Slices were then washed, mounted, and examined under a 
fluorescence microscope for detection of orexin A (Cy3), MCH (Cy2) immunoreactivity, 
and biocytin (AMCA). 
2.7 Data Analysis 
Current and voltage-clamp data was detected and analyzed using Clampfit 9.2 
software (Axon Instruments). miPSC's were further detected and analyzed using 
minianalysis 6.0 software (Synaptosoft, Decatur, GA). The data are expressed as mean ± 
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SE. Statistical comparisons were performed by using appropriate tests (i.e. , Kolmogorov 
Smirnov test for testing individual cells, and unpaired or paired Student's t tests, or 
ANOVA for group comparison as appropriate) . Dose response curves and EC5o 
calculations were performed using GraphPad Prism software. GraphPad Prism and 
minianalysis 6.0 were used for statistical analysis. A value ofp < 0.05 was considered to 
be significant. 
2.8 Chemical Compounds 
All drugs were bath perfused at fmal concentrations as indicated, by diluting 
aliquots of 1 OOOX stock in the ACSF immediately before use. DA and NE stock solutions 
included the anti-oxidant ascorbic acid (1 mM) and were light protected during the 
recordings to minimize oxidation. Dimethyl sulfoxide (DMSO) was used to solubilize 
appropriate compounds in stock solutions and the final concentration ofDMSO was 
0.1%. 
SKF 81297, quinpirole, SCH 23390, sulpiride, tertiapin-Q, yohimbine, BRL 
44408, and imiloxan were purchased from Tocris Bioscience (Ellisville, MO), dopamine, 
norepinephrine, biocytin, DNQX, and D-AP5 from Sigma Aldrich (St. Louis, MO), and 
tetrodotoxin from Alomone Labs (Jerusalem, Israel). 
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CHAPTER3 
Results 
3.1 Identification of MCH expressing neurons 
MCH expressing neurons were targeted based on their location within the LH and 
ZI and relatively large size. This was accomplished by using an IR-DIC microscope. 
However, orexin expressing neurons are also located in similar regions of the LH. 
Therefore, differentiating between the two types of cells was of extreme importance. 
Identification of MCH neurons was accomplished through immunohistochemical and 
electrophysiological means. Neurons were fi lled with biocytin via patch pipette, and 
their neurochemical phenotype was confirmed by an immunohistochemical method 
following recordings (Fig. 1Bl , B2). Cells that were found to be MCH immunopositive 
(n = 17) had distinct electrophysiological characteristics that were different from that 
displayed by orexin neurons (Fig. 1A1, A2). None of the MCH neurons displayed an Ih 
upon injection of a hyperpolarizing current and no rebound depolarization was reveled at 
the current offset. The average membrane potential was - 57.95 ± 1.54mV and the 
majority of them did not fire spontaneously ( 15 of 17, 88.2% ). Also, fourteen of the 
seventeen neurons (82.4%) displayed strong spike rate adaptation (Fig. 1A1, A2). These 
results are consistent with other previous studies (Alberto et al. , 2006;Eggermann et al., 
2003;Gao et al., 2003). 
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A total of 65 MCH neurons from 40 rats were used in this study of which 17 cells 
were identified as MCH immunopositive and having typical electrophysiological 
characteristics as described above. Forty-eight cells were identified based on the 
electrophysiological properties only. Cells that did not meet the criteria of MCH neurons 
were excluded from the study. 
3.2 Effect ofDA on MCH neurons (current-clamp) 
100 )..LM DA application caused a reversible hyperpolarization ofMCH neurons 
(Fig. 2A,top). Since one of the identifying characteristics ofMCH neurons is their lack of 
action potential firing at rest, a depolarizing current (200 pA, 300 msec) was given each 
minute to monitor DA's influence on action potential firing (Fig. 2A, bottom). As shown 
in Fig. 2B, 10 and 100 )..LM DA application caused a decrease in action potential firing 
and increased the latency to the first induced action potential (n = 2 respectively). In 
addition, DA application reduced input resistance during a -200 pA, 300 msec current 
pulse (Fig. 2B3, n = 2 respectively). However, DA application had no significant effect 
on spike threshold or width. Control values were - 32.15 ± 0.03mV and 3.9 ± 0.2 msec 
respectively, while during DA application values were -35.31 ± 0.26 mV and 3.4 ± 0.2 
msec respectively (n = 4, p>0.05). 
3.3 Postsynaptic effect ofDA on MCH neurons (voltage-clamp) 
It is possible that DA inhibits MCH activity by either acting directly on the MCH 
neuron or by influencing synaptic inputs. To investigate the possible postsynaptic 
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mechanism voltage-clamp experiments were carried out in the presence ofTTX (1 ~M). 
As shown in Fig. 3A, 100 ~M DA application caused a reversible outward current. This 
current is concentraion dependent (Fig. 3B) at concentrations tested (0.1 , 1, 3, 10 and 
100 ~M). 0.1 ~M DA application did not induce a significant outward current (0.19 ± 
0.08 pA, n = 3, p>0.05). The lowest concentration to produce a significant current was 1 
~M (8.94 ± 2.32 pA, n = 4, p<0.05). 3 ~M application induced a 17.37 ± 3.93 pA 
outward current (n= 5, p<0.05), while the current was also significant with the 10 and 
100 ~M application (22.99 ± 3.36 pA, n = 5, p<0.05 and 20.52 ± 2.38 pA, n=13, p<0.05 
respectively). Also, there was no statistical difference (p>0.05) for the currents produced 
from the 3, 10, or 100 ~M application. This indicates that a concentration of 3 ~M can 
initiate a maximal current with the DA's induced current having a steep concentration 
dependence. The EC5o ofthe DA induced outward current was 0.80 ~M. 
3.4 DA activates GIRK channels 
To determine the voltage dependence of the DA induced current the membrane 
potential was ramped before and during DA application and the resulting current 
response was measured (Fig. 4A 1 ). In the two experiments carried out the reversal 
potential for the DA induced current was -91mV, as shown in Fig. 4A2, and -89mV (data 
not shown). The results are similar to the predicted potassium reversal potential of the 
solutions used in our experiments (-101mV). TheDA induced current also displayed an 
inward rectification similar to the G Protein-activated Inwardly Rectifying K+ (GIRK) 
current. To determine the contribution ofGIRK channels to DA' s effect, DA was applied 
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in the presence of the GIRK channel blocker tertiapin-Q (300nM). In the presence of 
Tertiapin-Q a 1 00j.!M DA application failed to initiate an outward current. This was 
statistically different from DA application alone [(Fig. 4B; 2.91 ± 0.85pA, n = 3, p<0.05) 
(Fig. 4B2)]. This suggests that a GIRK mediated current is activated by DA application. 
3.5 Receptors mediating DA's response 
Next the receptor responsible for the outward current was investigated. There are 
two classes ofDA receptors, namely D1-like (Dl/D5) and D2-like receptors (D2/D3/D4). 
To examine the role of the receptors, the Dl-like agonist SKF81297 (10j.!M) and D2-like 
agonist quinpirole (1 0 j.!M) were simultaneously applied. To our surprise, these agonists 
failed to mimic the DA induced outward current [(Fig. SA); -1.55 ± 1.62, n = 5, p>O.OS 
(Fig. 5D)]. Furthermore, 100 j.!M DA induced a significant outward current when applied 
in the presence ofthe D1-like antagonist SCH23390 (10 j.!M) and the D2-like antagonist 
sulpiride (10 j.!M) [(Fig. 5B); 22.81 ± 5.13, n = 3, p<0.05 (Fig. 4D)]. This suggests that 
DA receptors are not mediating the DA effect. Furthermore, as shown in Fig. 5B, the DA 
receptor antagonists did not affect the MCH neuron on their own. This suggests that the 
DA receptor antagonists are not participating in the outward current. 
DA has the ability to activate adrenergic receptors (Brown & Caulfield, 1979) 
and activation of a 2-adreoceptors has been shown to hyperpolarize MCH neurons due to 
the activation ofGIRK channels (van den Pol et al., 2004). Therefore, we hypothesize 
that DA activates a2-adrenoceptors on MCH neurons which in turn initiates the outward 
current. 100 j.!M DA application in the presence of the a2-adreoceptor antagonist 
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yohimbine (5 j.!M) failed to induce an outward current [(Fig. 5C); -0.53 ± 0.44, n = 3, 
p>0.05, (Fig. 5D)]. This suggests dopaminergic activation of a2-adreoceptors mediates 
the outward current. a2-adreoceptors are classified into four subtypes, namely a2A, a28, 
a2c, and a2o- Due to the high expression level of the a2A and a2s adrenoceptor subtypes 
within the LH (Wang et al., 2002;WinzerSerhan et al., 1997), these were investigated. 
Application of 10-100 j.!M DA in the presence of a2A antagonist BRL44408 (3 j.!M) failed 
to induce an outward current [(100 j.!M, Fig. 6A); 10-lOOj..LM, 2.38 ± 2.11 , n = 5, p>0.05, 
(Fig. 6C)]. In contrast, application of 10-100 j.!M DA in the presence of a28 antagonist 
Imiloxan (3j..LM) induced an outward current [(100j.!M, Fig. 6B); 10-100j.!M, 16.77 ± 7.81 
n = 2, (Fig. 6C)]. This suggests dopaminergic activation of the a2A-adreoceptor subtype 
mediates the outward current. 
3.6 Comparison of DA vs NE effects on MCH neurons 
To determine whether DA was as effective as NE in modulating MCH neurons, 
the amplitude ofDA and NE induced outward currents was compared. We found that NE 
application initiated an outward current in a dose dependent manner in MCH neurons 
(Fig. 7 A and B). 0.1 j.!M NE application did not induce a significant outward current 
(3.10 ± 3.70 pA, n = 4, p>0.05). The lowest concentration ofNE to produce a significant 
current was 1j.!M (11.46 ± 4.49 pA, n = 4, p<0.05). 3j..LM application induced a 18.98 ± 
1.84 pA outward current ( n = 4,p<0.05), while the current was also significant with the 
10 and 100j.!M application ofNE( 21.20 ± 2.08 pA, n = 3, p<0.05 and 24.99 ± 2.38 pA, 
n=5,p<0.05 respectively). The EC5o ofthe NE induced outward current was 1.23 ).!M. As 
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shown in Fig. 7B the dose response curves of DA and NE are very similar with no 
significant differences between groups at concentrations tested (p>0.05), indicating that 
their effects are of similar magnitudes. In a preliminary experiment an occlusion test was 
carried out in an attempt to confirm if DA and NE were acting on the same receptor. As 
shown in Fig. 7C addition of 100 ).!M NE in the presence of 100 ).!M DAdoes not induce 
any further outward current, supporting the idea that the same receptor is activated. 
However, the possibility remains that DA and NE are both activating GIRK channels but 
through the activation of different subtypes of adrenoceptors receptors. 
3.7 Synaptic effect ofDA on MCH neurons (voltage-clamp) 
To determine possible synaptic effects of DA on MCH neurons, miPSCs were 
monitored in the presence ofTTX (1 ).!M). Application ofO.l , 1, 3, 10, and 100 ).!M DA 
had no consistent effect on rniPSC frequency (Fig. 8A1), with the change in miPSC 
frequency fluctuating independent of concentration. Some cells showed a significant 
increase in miPSC frequency during DA application. For example 100 ).!M DA 
application can increase the frequency of miPSCs (Fig. 8A2,p<0.05) while some cells 
were unchanged by 100 ).!M DA application (Fig. 8A3, p>0.05) However some cells had 
significantly decreased frequencies with DA application. For example, 100 ).!M DA 
application decreased the frequency of rniPSCs in some cells (Fig. 8A4, p <0.05). Also 
no consistent effect on miPSC amplitude was found with DA application (Fig. 8B). This 
suggests that DA induced hyperpolarization is not mediated by altered GABA release or 
GABA receptor activity 
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CHAPTER4 
Discussion 
4.1 Distinguishing MCH and Orexin neurons 
Animal studies have shown that MCH functions as an anabolic signal in energy 
homeostasis, communicates hedonic aspects of feeding, activates the stress axis, and 
decreases an animal's activity level. In order for the MCH neuropeptide to be fully 
understood, the factors influencing its neuronal activity must be identified. However, the 
orexigenic neuropeptide orexin is also expressed in similar regions of the hypothalamus 
as the MCH neurons. Although MCH and orexin are both synthesized by neurons of the 
LH and maintain many overlapping projections, the two peptides are not 
co-localized in a single neuron (Broberger et al. , 1998;Elias et al. 1998;Peyron et al. 
1998). Therefore, distinguishing between the two neuronal types is of extreme 
importance. This study began with the confirmation of the electrophysiological 
characteristics associated with MCH and orexin expressing neurons as described in 
earlier studies (Eggermann et al. , 2003;Gao et al., 2003). As shown in Fig. 1 our results 
confirmed the electrophysiological characteristics of both MCH and orexin neurons 
(Alberto et al. 2006). MCH neurons have a lower resting membrane potential compared 
to orexin neurons, do not fire spontaneously, show spike-rate adaptation, do not have an 
h, and do not display rebound depolarization. However, the orexin neuronal properties 
are different to that of MCH neurons because they have a higher resting membrane 
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potential, fire spontaneously, display no spike-rate adaptation, posses an Ih and do 
display rebound depolarization. Therefore these distinguishing electrophysiological 
characteristics can be used as a reliable tool in the identification of the MCH and orexin 
neuronal groups. 
4.2 DA hyperpolarizes MCH neurons 
Mesolimbic dopaminergic projections are positioned ideally for direct interaction 
with MCH neurons (Duva et al., 2005; Yoshida et al., 2006;Leibowitz & Brown, 1980). 
Behavioural studies have also suggested that this interaction may directly modulate the 
activity ofMCH neurons (Parada et al. , 1988;Yang et al. , 1997). Also, DA expressing 
neurons are located within the ZI, which in turn could directly influence MCH neurons 
(Cheung et al., 1998). The present study demonstrates that DA causes a reversible 
hyperpolarization of MCH neurons. As observed in Fig. 2, DA hyperpolarizes the 
membrane potential ofMCH neurons and reduces the action potential frequency. This 
reduction in action potential frequency coincides with the DA-induced increase in latency 
to the first action potential and to the decrease in input resistance. However the spike 
threshold and width are not affected. Therefore, the DA induced hyperpolarization may 
prevent MCH related behaviours, such as food intake, from being initiated. 
4.3 DA induces a GIRK mediated current 
DA may hyperpolarize MCH neurons through direct postsynaptic mechanisms, 
presynaptic mechanisms, or a combination of the two. As observed in Fig 3, during the 
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voltage-clamp protocol, when the MCH new-on is isolated from its synaptic inputs 
through the use of TTX, DA induces a direct dose-dependent reversible outward current. 
This indicates that DA may induce its hyperpolarization at least in part through direct 
postsynaptic mechanisms. As shown in Fig. 4, the cmrent-voltage relationship of the 
cmrent has an inward rectification with a reversal potential approximately equal to the K+ 
equilibrium potential. Fmthermore, the GIRK channel blocker tertiapin-Q abolished this 
cmrent. Thus we concluded that DA activates a GIRK cmrent in MCH neurons. 
G protein-dependent stimulation of potassium channels has been described for 
numerous nemotransmitters in a variety of brain regions. Stimulation of GIRK currents in 
the CNS has been shown to be pertussis toxin (PTX) sensitive (Saugstad et al., 1996), and 
hence the involvement of a Gi protein. Major nemotransmitters within the CNS can 
activate a hyperpolarizing GIRK current, which include: GABA by GABAs receptors in 
the hippocampus (Andrade et al. , 1986; Otis et al. , 1993), norepinephrine (NE) by a2-
adrenoceptors in the locus coeruleus (Velimirovic et al. , 199 5), 5-HT in the locus 
coeruleus and cerebellum (Andrade et al. , 1986: Andrade and Nicoll 1987), and by DA in 
the subtantia nigra and in the pituitary lactotrophs (Kim et al. , 1995). Activation of a 
GIRK current by NE has also been shown to induce the hyperpolarization of MCH 
neurons (van den Pol et al. , 2004). Therefore, DA may be activating the GIRK current in 
MCH neurons through the activation of DA receptors, or through an indirect adrenergic 
mechanism. 
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4.4 DA induced outward current is not DA receptor mediated 
It has been shown that addition of the 02-like receptor agonist quinpirole to brain 
slices hyperpolarizes substantia nigra neurons via the activation of a GIRK current during 
whole-cell patch clamp experiments (Kim et al., 1995). The GIRK current was blocked 
using the 02-like receptor antagonist sulpiride suggesting the direct activation of the 02-
like receptor initiated the activation of GIRK channels, which led to the 
hyperpolarization. In contrast, as shown in Fig. 5, simultaneous application of 01 and 02 
receptor agonists failed to mimic the OA induced outward current in MCH neurons. To 
ensure the 01 agonist was not counteracting a 02 initiated current, the 02-like agonist 
quinpirole was applied alone in some cells. Activation of 02 receptors alone also failed 
to initiate an outward current (data not shown). Furthermore addition of OA receptor 
antagonist failed to block the OA induced current. This suggests that OA is not initiating 
the GIRK current through a OA receptor based mechanism. 
Evidence for OA receptor expression within the LH area is conflicting. One study 
on Zucker rats concluded that both 01 and 02 receptor mRNAs were present within the 
LH (Fetissov et al. , 2002). PCR preparation for this study used a brain tissue chunk 
containing the LH. With this type of tissue preparation it is possible that surrounding 
areas outside of the LH were incorporated into the analysis. Therefore, a false positive 
may have been obtained with the OA receptors actually expressed outside the LH. A 
more recent study on SO rats, that used the spatially specific in-situ hybridization 
method, showed that 02 mRNA was scarce within the LH and 01 mRNA was not 
present (Bubser et al. , 2005). However, these conflicting results may be due to the rat 
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strains used. The present study was undertaken with SD rats, therefore the low level on 
D2 expression and absence ofD1 may explain why the D1-and D2-like agonists and 
antagonists had no effect on MCH neuronal activity. This suggests that the GIRK cwTent 
is initiated through a DA receptor independent mechanism. 
4.5 DA induced outward current is a2A-adrenoceptor mediated 
The possibility of insufficient DA receptor expression suggests that DA may be 
acting within the LH through the activation of adrenergic receptors. Evidence supporting 
this includes the fact that a2 - adrenoceptors are heavily expressed within the LH (Wang 
et al. , 2002; WinzerSerhan et al. , 1997). As previously shown by van den Pol et al. , 
(2004), NE has the ability to induce a hyperpolarizing GIRK current through the 
activation of the PTX sensitive a2-adrenoceptors in MCH neurons. DA and NE are both 
catacholaminergic neurotransmitters and DAis known to show cross reactivity to 
adrenergic receptors (Brown & Caulfield, 1979). Therefore, the possibility exists that DA 
is initiating the outward current through the activation of the adrenergic system. As 
observed in Fig. 5, blocking the a 2-adrenoceptors prevents the initiation of the DA 
induced outward current. The a 2A and a23 adrenoceptor subtypes are the most 
predominantly expressed a2-adrenoceptors in the LH area (Wang et al., 
2002; WinzerSerhan et al. , 1997). Further investigation into the receptor subtype revealed 
that the a 2A receptor activation was initiating the outward current. 
NE itself shares similarities with DA' s influence on MCH related behaviours, 
such as inhibiting food intake (Wellman et al. 1993). On the other hand earlier studies 
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demonstrated that NE release within the hypothalamus was increased during feeding 
(Hoebel et al., 1989), and that NE dose-dependently increased food intake by chemical 
stimulation of the LH (Shiraishi, 1991). Wellman et al. (1993) demonstrated that NE 
effect on food intake was dependent on which adrenergic receptor was activated within 
the para ventricular nucleus of the hypothalamus. When a2- receptors are activated it 
increased food intake, however a 1 ~ activation decreased food intake. Therefore a 
possible explanation ofNE's opposing influence on ingestive behaviour may be due to 
the type of adrenergic receptor that is activated and its location in the hypothalamus. All 
adrenergic receptors are G-protein coupled with the a 1-receptors coupled to Gq, while the 
a2- are coupled to the Gi, and the adrenergic 13-receptors are G5 coupled, for review see 
Michelotti et al., (2000). Therefore, the possibility exists that activation of the inhibitory 
Gi protein within the orexigenic MCH neuronal population by the a2-adrenoceptors 
would inhibit their activity and thus decrease food intake. On the other hand activation of 
the stimulatory G5 protein and even the Gq proteins within the LH by the a,- and 13-
receptors may stimulate the MCH and/or orexin neurons and thus increase food intake. 
Evidence supporting this hypothesis is the fact that a,-, a2, and 13-adrenoceptors are all 
expressed within the LH (Wang et al. , 2002; WinzerSerhan et al. , 1997; Day et al., 1997; 
Castillo-Melendez et al. , 2000), while NE action within the hypothalamus produces 
conflicting effects on food intake. 
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4.6 DA mimics NE's effect on MCH neurons 
Activation of adrenoceptors within the CNS has been shown to reduce food intake 
(Wellman et al., 1993). This evidence taken with the fact that NE activation of a2-
adrenoceptors directly hyperpolarizes MCH neurons, suggests that NE may interact with 
MCH neurons to inhibit food intake. Also MCH is known to activate the stress responses 
and induces depressive- and anxiety-like behaviours, while the blockade ofMCH 
receptors results in antidepressant and anxioJytic effects in various models (Kennedy et 
al. , 2003;Borowsky et al., 2002). With this in mind, preventing the release of the MCH 
neuropeptide into the CNS through adrenergic inhibition ofMCH neurons may result in 
altered HPA axis function. This is indeed the fact with altered HP A axis activation 
resulting from an increase in central adrenergic signaling (Morilak et al., 2005). 
Therefore adrenergic activation of a2-adrenoceptors on MCH neurons may result in the 
direct regulation of food intake and the stress response. Since NE and DA both inhibit 
MCH neuronal activity through the activation of a2-adrenoceptors, which may result in 
altered MCH related behaviours, the questions arise whether DA's effects on MCH 
neurons through the adrenergic receptor are of a similar magnitude to the effect ofNE 
itself, and secondly whether the same a2-adrenoceptors are being activated. 
As observed in Fig. 7, NE produced a dose dependent reversible outward current 
that is in agreement with previous research (van den Pol et al., 2004). The amplitude of 
the outward current induced by NE and DA is similar at the same concentrations. Even 
though our data suggest that DA shows cross reactivity with adrenergic receptors this 
28 
observation was surprising due to the fact that DA has an affinity for a.2-adrenoceptors 
10-28-fold lower than that ofNE (Cornil and Ball, 2008). Cornil and Ball (2008) 
demonstrated this lower affinity in whole rat brain homogenates, therefore the possibility 
remains that anatomical specificity may determine the magnitude of DA and NE cross 
reactivity and that DA may have a higher affinity for a.2-adrenoceptors within the LH in 
order to compensate for the low DA receptor expression. 
To examine whether the outward current was initiated through the same receptors 
an occlusion experiment was conducted. As shown in Fig. 7, the addition ofNE in the 
presence of DA did not alter the outward current suggesting that in fact the same a.2-
adrenoceptors mediated the outward current. Therefore it can be concluded that DA is 
regulating the same adrenergic system in MCH neurons as NE itself, and with similar 
efficacies. 
4.7 DA's hyperpolarization ofMCH neurons is not synaptically mediated. 
Since MCH neuronal activity is modulated by GABA and glutamate transmission 
(van den Pol et al. , 2004), the possibility remains that dopaminergic modulation of 
glutamate and/or GABA synapses may contribute to its inhibitory effect on MCH 
neuronal activity. To aid in determining the synaptic influence of a neurotransmitter, 
rnlPSC' s and miniature excitatory postsynaptic currents (rnEPSC' s) can be utilized as an 
electrophysiological tool. Miniature events inform the researcher on the spontaneous 
release of transmitters that are action potential independent. Therefore, how a compound 
influences the release machinery ofthe presynaptic terminals and the conductivity of the 
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postsynaptic channels can be studied. Previous research within our laboratory focused on 
DA' s influence on mEPSC' s and miPSC' s in orexin neurons within the LH. These 
studies found that DA decreases glutamate release and increases GABA release onto 
orexin neurons (Alberto et al. , 2006; Trask et al. , 2005). In contrast, we have found in the 
present study that DA has no consistent effect on rniPSC frequency or amplitude in MCH 
neurons (Fig. 8), regardless of the concentration used. DA influenced the frequency and 
amplitude ofmiPSC's by increasing them in some cells, decreasing in some, and having 
no effect in others. Previous research within the laboratory also revealed that DA had no 
effect on mEPSC frequency or amplitude in MCH neurons. Taken together, our results 
suggest that synaptic modulation of glutamate and GABA receptors is not a mechanism 
by which DA inhibits MCH neurons. 
4.8 Conclusion 
From this study it can be concluded that DA hyperpolarizes MCH neurons 
through the activation of a GIRK current by the direct postsynaptic activation of a 2A-
adrenoceptors. In general the inhibition ofMCH neurons by DA may help explain DA' s 
influence on MCH related behaviours, such as DA' s anorexigenic properties when acting 
within the LH. More specifically this is the first study to demonstrate a cross talk between 
DA and adrenergic signaling at the cellular level within the LH area. If the DA receptor 
expression is low in the LH, as Bubser et al. , (2005) suggested, then this cross talk may 
provide an explanation on how the DA input to the LH can influence MCH related 
behaviours. This study suggests that the abundant postsynaptic expression of a 2A-
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adrenoceptors within the LH may serve as the mediator necessary for DA effects. This 
mechanism may also help explain why DA and NE have similar effects on MCH related 
behaviours. 
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Figure 1. Identification ofMCH and orexin neurons. Al, Electrophysiological 
characteristics of an MCH neuron. In a typical MCH neuron, hyperpolarization does not 
induce an H current and there is no rebound depolarization at the current offset. There are 
no spontaneous action potential firing at rest and depolarization induces a strong spike 
rate adaptation(i). A2, Electrophysiological characteristics of an Orexin neuron. In a 
typical orexin neuron, hyperpolarization induces an H current{ii) and there is a rebound 
depolarization at the current offset(iii). There are spontaneous action potential firing at 
rest and depolarization does not induce spike rate adaptation. Bl, Immunohistological 
identification of a recorded MCH neuron. Left, an example of a cell filled with biocytin 
during recording. Middle, MCH immunoreactivity is shown in green. Right, overlay 
showing the biocytin labeled cell is MCH-immunopositive. B2, Immunohistological 
identification of a recorded orexin neuron. Left, an example of a cell filled with biocytin 
during recording. Middle, orexin A neuropeptide immunoreactivity is shown 
in red. Right, overlay showing the biocytin labeled cell is orexin A-immunopositive. 
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Figure 2. DA hyperpolarizes and diminishes firing ofMCH neurons. A, Top, Typical 
recording showing the effect of 1 OOJ1M DA. The bar above the trace indicates application 
ofDA. Vertical lines are responses to current injections (-200-200pA). Bottom, 
Representative recording during 200pA injections in expanded time scale taken at the 
time points indicated by each arrow. Note the reduction in action potential firing and the 
increase in action potential latency during DA application. Bl, Effect of 10 and 1 OOJ1M DA 
on action potential firing during a 200pA, 300ms current step .. B2, Effect of 10 andlOOJ.LM 
DA on the latency to the first action potential during a 200pA, 300ms current step. 
BJ, Effect of 10 and100J1M DA on input resistance during a 200pA, 300ms current step. 
Error bars indicate SE. Numbers above and within bars represents the number of 
samples used .. 
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Figure 3. DA induces a concentration dependent outward current in MCH neurons. 
A, Typical recording showing the effect of 1 00~ DA. B, Summary of DA effect at 
different concentrations. *p<O.OS. Error bars indicate SE. Numbers above and within 
bars represents the number of samples used. 
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Figure 4. DA-induced outward current due to the activation of GIRK channels in MCH 
neurons. Al, Representative traces showing the effect ofDA application on I-V 
relationship during a 600ms voltage ramp. A2,Representative trace showing the total DA 
induced current with a reversal potential of -9lpA (arrow). Bl, Typical recording showing 
the effect of 1 OOJ!M DA in the presence of Tertiapin-Q (300nM). B2, Summary of the 
effect of lOOJ!M DA in the presence ofTertiapin-Q (300nM). *p<0.05 . Error bars 
indicate SE. Numbers above and within bars represents the number of samples used. 
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Figure 5. DA-induced outward current is initiated through the activation of 
alph~-adrenoceptors and not DAreceptors in MCH neurons. A, Typical recording 
showing the effect of SKF81297 (lOJ.1M) and Quinpirole (10J.1M). B, Typical recording 
showing the effect of lOOJ.1M DAin the presence ofSCH23390 (10J.1M) and 
Sulpiride (lOJ..LM). C, Typical recording showing the effect of lOOJ..LM DA in the presence 
ofYohimbine (5J..LM). D, Summary of the effect ofDA, SKF81297 plus Quinpirole, DAin 
the presence of SCH23390 and Sulpiride, DA in the presence of Yohimbine on MCH 
neurons. Concentration ofDA used was 10-lOOJlM. *p<0.05. Error bars indicate SE. 
Numbers above and within bars represents the number of samples used .. 
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Figure 6. DA-induced outward current is due to the activation of a 2A-adrenoceptors in 
MCH neurons. A, Typical recording showing the effect of 100~ DA in the presence of 
BRL44408 (3J.!M). B, Typical recording showing the effect of lOOJ.!M DA in the 
presence of Imiloxan (3 J.!M). C, Summary of the effect on DA, DA in the presence of 
BRL 44408, DA in the presence oflmiloxan on MCH neurons. The concentration ofDA 
used was 10-lOOJ.!M. *p<0.05. Error bars indicate SE. Numbers above and within bars 
represents the number of samples used. 
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Figure 7. DA and NE-induced outward currents are similar in MCH neurons. A, Typical 
recording showing the effect of 1 OOJ.1M NE. B, Concentration dependence ofDA and 
NE-induced outward currents.Number of samples used: 0.1J.1M (DA=3 NE=4), 
1~M (DA=4 NE=4), 3~M (DA=5 NE=4), 10J.1M (DA=5, NE=3),100~M (DA=13, NE=5). 
C, Preliminary recording showing the effect of 1 OOJ.!M NE in the presence of 1 OOJ.!M DA. 
Error bars indicate SE. 
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Figure 8. DA has no consistent effect on mlPSC frequency or amplitude. Al, Summary 
ofthe effect ofvarious concentrations ofDAon mlPSC frequency (each filled circle 
represents a single cell). A2, A3, A4, Representative time effect plots of 1 00~ DA 
effect on miPSC frequency. B, Summary of the effect of various concentrations ofDA 
on mlPSC Amplitude (each filled circle represents a single cell). 
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